共 50 条
Emerging role of inositol monophosphatase in cancer
被引:3
|作者:
Chen, Qian
[1
,2
]
Shen, Liangfang
[1
,2
]
Li, Shan
[1
,2
,3
]
机构:
[1] Cent South Univ, Xiangya Hosp, Dept Oncol, Changsha, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Dept Geriatr, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China
[3] 87 Xiangya Rd, Changsha 410008, Peoples R China
关键词:
IMPase;
IMPA1;
IMPA2;
Myo-inositol;
Cancer;
MYOINOSITOL MONOPHOSPHATASE;
IMPA2;
GENE;
BIPOLAR DISORDER;
BREAST-CANCER;
LITHIUM;
ASSOCIATION;
EXPRESSION;
CELLS;
RISK;
SCHIZOPHRENIA;
D O I:
10.1016/j.biopha.2023.114442
中图分类号:
R-3 [医学研究方法];
R3 [基础医学];
学科分类号:
1001 ;
摘要:
Inositol monophosphatase (IMPase) is an enzyme with two homologs-IMPA1 and IMPA2-that is responsible for dephosphorylating myo-inositol monophosphate to generate myo-inositol. IMPase has been extensively studied in neuropsychiatric diseases and is regarded as a susceptibility gene. Recently, emerging evidence has implied that IMPase is linked to cancer development and progression and correlates with patient survival outcomes. Interestingly, whether it acts as a tumor-promoter or tumor-suppressor is inconsistent among different research studies. In this review, we summarize the latest findings on IMPase in cancer, focusing on exploring the underlying mechanisms for its pro- and anticancer roles. In addition, we discuss the potential methods of IMPase regulation in cancer cells and the possible approaches for IMPase intervention in clinical practice.
引用
收藏
页数:10
相关论文